Moderna exits gene editing deal worth up to $3B biobucks, leaving Metagenomi in the spotlight aarmstrong Wed, 05/01/2024 - 13:53

Pfizer plans to be 'very active' in obesity market, but CEO mum on precise R&D plans mbayer Wed, 05/01/2024 - 13:55

Astellas hitches a ride in Poseida's convertible for $50M cell therapy collaboration aarmstrong Wed, 05/01/2024 - 12:15

Hologic picks up magnetic breast cancer marker maker Endomag for $310M chale Wed, 05/01/2024 - 11:46

Quest Diagnostics carves out PathAI’s digital pathology lab, plots AI ramp up chale Wed, 05/01/2024 - 10:34

Bob Nelsen on ARCH-led megarounds: ‘We want the IPO book in the seed round’ mbayer Wed, 05/01/2024 - 10:19